Inventor · disambiguated record
Xiben Li
Also filed as: LI XIBEN
4 granted patents·7 pending applications·4 citations·filing 2018–2025
61Inventor score
Top patents by PatentIndex Score
11 records- 0194US11945830B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Granted Apr 2, 2024·3 cites·18 claims
- 0289US12162857B2Antiviral compoundsENANTA PHARM INC·Filed 2023·Granted Dec 10, 2024·1 cites·15 claims
- 0374US12358921B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2023·Granted Jul 15, 2025·0 cites·16 claims
- 0469US2025368659A1Antiviral Heterocyclic CompoundsENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 0566US2024368174A1Antiviral Heterocyclic CompoundsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0658US2023242565A1Macrolides with Modified Desosamine Sugars and Uses ThereofZIKANI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0757US2023115580A1Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Application pending·0 cites
- 0852US2025313569A1Pharmaceutical Compounds And Compositions As Modulators Of MAS-Related G-Protein Receptor X2ENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 0945US2024277747A1Compounds for Treating Genetic DiseasesZIKANI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1038US11673910B2Macrolides with modified desosamine sugars and uses thereofZIKANI THERAPEUTICS INC·Filed 2018·Granted Jun 13, 2023·0 cites·3 claims
- 1132US2022177508A1C10-Cyclic Substituted 13-Membered Macrolides and Uses ThereofZIKANI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiben Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →